165 filings
Page 3 of 9
8-K
8k4qaew03gdxltrgy
15 Jul 22
Other Events
5:06pm
8-K/A
r7w nlyvy
21 Jun 22
Other Events
5:15pm
8-K
3m3llxkgl1xkro 8rta
21 Jun 22
Other Events
7:06am
8-K
ewn xvc7r4vn
21 Jun 22
Other Events
6:40am
8-K
ph7vk8s6sj41zz
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
6dtsy szpp50629yp
15 Jun 22
Other Events
8:24am
8-K
y00c3
11 May 22
TRACON Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:09pm
8-K
77jlogv4x78cktud0ic8
15 Mar 22
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
4:10pm
8-K
papi5wdr
5 Jan 22
Results of Operations and Financial Condition
8:14am
8-K
4iigy1550l7pzu
27 Dec 21
Pre-specified Interim Analysis Concluded with Recommendation to Continue the ENVASARC Trial
9:36am
8-K
etkc2sjq1jl1
3 Nov 21
TRACON Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:08pm
8-K
ppcppi qoxy
13 Oct 21
TRACON Pharmaceuticals Announces Appointment of Carol Lam to its Board of Directors
8:08am
8-K
eqetd71sioyafq2 hel
12 Oct 21
TRACON Pharmaceuticals and Eucure Biopharma, a Subsidiary of Biocytogen, Announce Partnership for Development of Clinical Stage CTLA-4 Antibody YH001
6:03am
8-K
7y9ceuhi 6p4jbus3apo
11 Aug 21
TRACON Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:09pm
8-K
5kjus
22 Jul 21
Other Events
4:57pm
8-K
nc2nncgymn4ycl33r0b3
30 Jun 21
Departure of Directors or Certain Officers
8:11am
8-K
tp5moc
11 Jun 21
Departure of Directors or Certain Officers
4:13pm
8-K
hb9pldnb2okmu5zw
5 May 21
TRACON Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:11pm
8-K
4f1p 3ev0nqz8c3b
15 Mar 21
Departure of Directors or Certain Officers
4:37pm
8-K
60vmjowkvtqp36c
8 Mar 21
TRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors
8:14am